Keith Sullivan - Sientra Director Business

SIENDelisted Stock  USD 4.29  0.37  9.44%   

Director

Mr. Keith J. Sullivan is the Director of the Company. Mr. Sullivan most recently was Chief Commercial Officer and President, North America of ZELTIQ Aesthetics, Inc., a medical technology company focused on developing and commercializing products utilizing its proprietary controlledcooling technology platform under the Coolsculpting brand. Mr. Sullivan led the restructuring of the global commercial organization resulting in a nearly 50 percent 4year CAGR leading to an acquisition this year by Allergan. Mr. Sullivan, who has more than 30 years of senior sales leadership experience in the medical device industry, has previously held leadership positions with Medicis Pharmaceuticals, Reliant Technologies, Medtronic, Vision Quest Laser and Coherent Medical since 2017.
Age 66
Tenure 7 years
Phone805 562 3500
Webhttps://sientra.com
Sullivan received a Bachelor of Business Administration from the College of William and Mary.

Keith Sullivan Latest Insider Activity

Tracking and analyzing the buying and selling activities of Keith Sullivan against Sientra stock is an integral part of due diligence when investing in Sientra. Keith Sullivan insider activity provides valuable insight into whether Sientra is net buyers or sellers over its current business cycle. Note, Sientra insiders must abide by specific rules, including filing SEC forms every time they buy or sell Sientra'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Sientra Management Efficiency

The company has return on total asset (ROA) of (0.2057) % which means that it has lost $0.2057 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (9.3425) %, meaning that it created substantial loss on money invested by shareholders. Sientra's management efficiency ratios could be used to measure how well Sientra manages its routine affairs as well as how well it operates its assets and liabilities.
Sientra currently holds 63.16 M in liabilities with Debt to Equity (D/E) ratio of 9.32, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Sientra has a current ratio of 1.37, which is within standard range for the sector. Note, when we think about Sientra's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Joel SuiterSurModics
N/A
Maria SainzAvanos Medical
55
Filippo PasseriniInteger Holdings Corp
63
John ByrnesAvanos Medical
62
ChihHeng LuAinos Inc
44
Patrick OLearyAvanos Medical
63
Martin MaxwellInteger Holdings Corp
62
William SummersInteger Holdings Corp
70
James HinrichsInteger Holdings Corp
53
Pamela BaileyInteger Holdings Corp
72
Alvin JeffersInteger Holdings Corp
47
Kristina WrightParagon 28
47
Sheila AntrumInteger Holdings Corp
62
William HawkinsAvanos Medical
65
Julie ShimerAvanos Medical
68
Cheryl BlanchardAnika Therapeutics
60
Jeffrey BurbankArtivion
58
Cheryl CappsInteger Holdings Corp
59
Heidi KunzAvanos Medical
66
Donald SpenceInteger Holdings Corp
67
Jean HobbyInteger Holdings Corp
60
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California. Sientra operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 319 people. Sientra (SIEN) is traded on New York Stock Exchange in USA and employs 304 people.

Management Performance

Sientra Leadership Team

Elected by the shareholders, the Sientra's board of directors comprises two types of representatives: Sientra inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sientra. The board's role is to monitor Sientra's management team and ensure that shareholders' interests are well served. Sientra's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sientra's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark Saxton, Senior Sales
Lisa Rosas, VP Marketing
Oliver Bennett, Chief VP
Caroline Hove, Executive Directors
Andrew Schmidt, Treasurer VP
Adelle Walker, Senior Marketing
Denise Dajles, Regulatory RD
Matt Hostetler, Chief Officer
Ronald Menezes, CEO President
Jeffrey Jones, VP Operations
Keith Sullivan, Director Business

Sientra Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sientra a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Sientra

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sientra position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sientra will appreciate offsetting losses from the drop in the long position's value.

Moving against Sientra Stock

  0.87PPERY Bank Mandiri PerseroPairCorr
  0.85JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.84BKRKY Bank RakyatPairCorr
  0.8PBCRY Bank Central AsiaPairCorr
  0.8PTBRY Bank Negara Indonesia Normal TradingPairCorr
The ability to find closely correlated positions to Sientra could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sientra when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sientra - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sientra to buy it.
The correlation of Sientra is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sientra moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sientra moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sientra can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Consideration for investing in Sientra Stock

If you are still planning to invest in Sientra check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sientra's history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk